Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target
Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target
Needham重申買入Avadel Pharmicals，維持22美元的目標股價
Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $22 price target.
紐汗姆分析師阿米·法迪（Ami Fadia）重申售出avadel pharmaceuticals（納斯達克：AVDL）並將目標價維持在22美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。